Works matching DE "HEMOPHILIA treatment"
Results: 1324
The Benefits of Sustaining High Factor VIII Levels in People With Hemophilia A.
- Published in:
- American Journal of Managed Care, 2025, p. S15, doi. 10.37765/ajmc.2025.89703
- By:
- Publication type:
- Article
Quality-of-Life Assessment and Pharmacokinetic Study in Hemophilia A Patients Undergoing Prophylactic Treatment.
- Published in:
- Pharmacy, 2025, v. 13, n. 1, p. 16, doi. 10.3390/pharmacy13010016
- By:
- Publication type:
- Article
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review: Economic Burden of Haemophilia from a Societal Perspective: A. A. El-Sayed, N. S. Bolous.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 179, doi. 10.1007/s41669-024-00540-4
- By:
- Publication type:
- Article
Social consequences of infected haemophilia cases in the Islamic Republic of Iran.
- Published in:
- Eastern Mediterranean Health Journal, 2011, v. 17, n. 6, p. 552, doi. 10.26719/2011.17.6.552
- By:
- Publication type:
- Article
Bleeding Disorders in Women and Girls: State of the Science and CDC Collaborative Programs.
- Published in:
- Journal of Women's Health (15409996), 2022, v. 31, n. 3, p. 301, doi. 10.1089/jwh.2022.0008
- By:
- Publication type:
- Article
From Virus to vector to medicine: Foreword by guest editors.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Stable and high-level production of recombinant Factor IX in human hepatic cell line.
- Published in:
- Biotechnology & Applied Biochemistry, 2011, v. 58, n. 4, p. 243, doi. 10.1002/bab.32
- By:
- Publication type:
- Article
Bleeding management: rFVIIIFc in hemophilia A and liver transplantation.
- Published in:
- Die Anaesthesiologie, 2023, v. 72, n. 12, p. 883, doi. 10.1007/s00101-023-01320-1
- By:
- Publication type:
- Article
血友病性关节病预防治疗效果的超声评估.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 18, p. 3452, doi. 10.13241/j.cnki.pmb.2024.18.009
- By:
- Publication type:
- Article
Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
- Published in:
- Collegium Antropologicum, 2016, v. 40, n. 2, p. 139
- By:
- Publication type:
- Article
Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 854, doi. 10.3390/biom14070854
- By:
- Publication type:
- Article
Equidade em situações-limite: acesso ao tratamento para pessoas com hemofilia.
- Published in:
- Revista Bioetica, 2022, v. 30, n. 1, p. 181, doi. 10.1590/1983-80422022301518PT
- By:
- Publication type:
- Article
Thirty Years of the Journal Haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1255, doi. 10.1111/hae.15127
- By:
- Publication type:
- Article
Haemophilia testing of young girls in Canada: Describing the current recommendations for factor level and genetic testing and the experiences of Canadian parents.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1393, doi. 10.1111/hae.15107
- By:
- Publication type:
- Article
Development of the World Federation of Hemophilia Shared Decision‐Making Tool.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1298, doi. 10.1111/hae.15100
- By:
- Publication type:
- Article
Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1321, doi. 10.1111/hae.15094
- By:
- Publication type:
- Article
Differences and similarities in patient‐reported outcomes among men and women with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1383, doi. 10.1111/hae.15090
- By:
- Publication type:
- Article
Real world management of individuals with severe FXI deficiency and its impact on clinical outcomes: Experience from a haemophilia treatment centre.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1164, doi. 10.1111/hae.15075
- By:
- Publication type:
- Article
Sexual functioning in men with haemophilia: Data from the haemophilia in the Netherlands‐6 study.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1243, doi. 10.1111/hae.15083
- By:
- Publication type:
- Article
Recombinant FVIII replacement products for haemophilia A: An updated valuation by indirect comparison measuring area under the curve.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1230, doi. 10.1111/hae.15076
- By:
- Publication type:
- Article
A clinical practice guideline for primary care physiotherapy in patients with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1115, doi. 10.1111/hae.15065
- By:
- Publication type:
- Article
Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1217, doi. 10.1111/hae.15063
- By:
- Publication type:
- Article
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1109, doi. 10.1111/hae.15031
- By:
- Publication type:
- Article
Preference of treatment characteristics among people with haemophilia or their caregivers, and physicians in the Japanese healthcare environment.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 914, doi. 10.1111/hae.15028
- By:
- Publication type:
- Article
Shared decision‐making related to treatment of haemophilia: A scoping review of influential factors and available support tools.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 880, doi. 10.1111/hae.15026
- By:
- Publication type:
- Article
Mutational landscape, inhibitor development, and health‐care burden in non‐severe haemophilia A: A single‐centre Australian experience.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 638, doi. 10.1111/hae.15007
- By:
- Publication type:
- Article
Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 577, doi. 10.1111/hae.15001
- By:
- Publication type:
- Article
Health utilities in adults with hemophilia A: A retrospective cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 733, doi. 10.1111/hae.14979
- By:
- Publication type:
- Article
Emicizumab use in infancy: A survey of United States Pediatric Hemophilia Treatment Center Medical Directors.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 848, doi. 10.1111/hae.14959
- By:
- Publication type:
- Article
Riding the wave of change: Providing solid ground to support nursing with patient transitions to novel haemophilia therapies.
- Published in:
- Haemophilia, 2024, v. 30, p. 135, doi. 10.1111/hae.15003
- By:
- Publication type:
- Article
Outcomes and outcome measures.
- Published in:
- Haemophilia, 2024, v. 30, p. 112, doi. 10.1111/hae.14990
- By:
- Publication type:
- Article
Women and girls with inherited bleeding disorders: Focus on haemophilia carriers and heavy menstrual bleeding.
- Published in:
- Haemophilia, 2024, v. 30, p. 45, doi. 10.1111/hae.14983
- By:
- Publication type:
- Article
Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies.
- Published in:
- Haemophilia, 2024, v. 30, p. 39, doi. 10.1111/hae.14976
- By:
- Publication type:
- Article
Diagnosis and treatment challenges in lower resource countries: State‐of‐the‐art.
- Published in:
- Haemophilia, 2024, v. 30, p. 78, doi. 10.1111/hae.14956
- By:
- Publication type:
- Article
Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 345, doi. 10.1111/hae.14960
- By:
- Publication type:
- Article
Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 355, doi. 10.1111/hae.14946
- By:
- Publication type:
- Article
The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 437, doi. 10.1111/hae.14943
- By:
- Publication type:
- Article
Joint bleeds in mild hemophilia: Prevalence and clinical characteristics.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 331, doi. 10.1111/hae.14939
- By:
- Publication type:
- Article
Patient and caregiver preferences for haemophilia treatments: A discrete‐choice experiment.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 375, doi. 10.1111/hae.14928
- By:
- Publication type:
- Article
The psychosocial impact of haemophilia from patients' and caregivers' point of view: The results of an Italian survey.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 449, doi. 10.1111/hae.14926
- By:
- Publication type:
- Article
Observational cohort study of long‐term outcomes of liver transplantation in haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 87, doi. 10.1111/hae.14910
- By:
- Publication type:
- Article
Perspectives and perception of haemophilia gene therapy by French patients.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 68, doi. 10.1111/hae.14908
- By:
- Publication type:
- Article
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 232, doi. 10.1111/hae.14912
- By:
- Publication type:
- Article
A pilot study of US HTC physical therapists' concordance of PT MASAC recommendations and educational needs.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 169, doi. 10.1111/hae.14900
- By:
- Publication type:
- Article
Direct data transfer of people with hereditary bleeding disorders from the Thai haemophilia treatment centre registry to the Annual Global Survey of the World Federation of Hemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 245, doi. 10.1111/hae.14897
- By:
- Publication type:
- Article
Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1442, doi. 10.1111/hae.14887
- By:
- Publication type:
- Article
The World Health Organisation's list of essential medicines and haemophilia treatment products.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1387, doi. 10.1111/hae.14879
- By:
- Publication type:
- Article
Delivery of gene therapy in haemophilia treatment centres in the United States: Practical aspects of preparedness and implementation.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1430, doi. 10.1111/hae.14867
- By:
- Publication type:
- Article
A 10‐year single‐institution retrospective review of treatment for acquired hemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1656, doi. 10.1111/hae.14856
- By:
- Publication type:
- Article
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres.
- Published in:
- Haemophilia, 2023, v. 29, n. 5, p. 1291, doi. 10.1111/hae.14847
- By:
- Publication type:
- Article